Products

What will AGI do for Adaprolol maleate?

This classification denotes a beta-adrenergic blocking agent with the molecular formula C26H39NO4.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2I8RV6WL9A, chemically known as benzeneacetic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 2-tricyclo(3.3.1.1(sup 3,7))dec-1-ylethyl ester, (+-)-, (z)-2-butenedioate (1:1) (salt) but more generally known as adaprolol maleate, which bears US NIH Compound Identifier 6435805. Most nations, for tariff and trade purposes, schedule adaprolol maleate under HS 29221980 and SITC 51461. As of Q4 2014, ADAPROLOL MALEATE remains US FDA's Preferred Term for this commodity. Adaprolol maleate bears US NLM identifiers UMLS ID C0645353 and NCI Concept Code C79960. SMILES: CC(C)NCC(COC1CCC(CC1)CC(=O)OCCC23CC4CC(C2)CC(C4)C3)O.C(=C\C(=O)O)\C(=O)O.

How AGI delivers it

Four ways AGI delivers for Adaprolol maleate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Adaprolol maleate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Adaprolol maleate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Adaprolol maleate connects

measured by

  • Assay Puritymodel
  • Salt Stoichiometrymodel
  • Water Contentmodel